Amicogen Balance Sheet Health
Financial Health criteria checks 1/6
Amicogen has a total shareholder equity of ₩219.7B and total debt of ₩148.4B, which brings its debt-to-equity ratio to 67.6%. Its total assets and total liabilities are ₩467.1B and ₩247.4B respectively. Amicogen's EBIT is ₩689.4M making its interest coverage ratio 0.1. It has cash and short-term investments of ₩38.6B.
Key information
67.6%
Debt to equity ratio
₩148.44b
Debt
Interest coverage ratio | 0.06x |
Cash | ₩38.55b |
Equity | ₩219.67b |
Total liabilities | ₩247.43b |
Total assets | ₩467.10b |
Recent financial health updates
Recent updates
Amicogen, Inc. (KOSDAQ:092040) Held Back By Insufficient Growth Even After Shares Climb 39%
Mar 21With EPS Growth And More, Amicogen (KOSDAQ:092040) Is Interesting
Mar 23Should Amicogen (KOSDAQ:092040) Be Disappointed With Their 24% Profit?
Mar 05Is Amicogen (KOSDAQ:092040) A Risky Investment?
Feb 15What Kind Of Investors Own Most Of Amicogen, Inc. (KOSDAQ:092040)?
Jan 31Could The Market Be Wrong About Amicogen, Inc. (KOSDAQ:092040) Given Its Attractive Financial Prospects?
Jan 14Amicogen (KOSDAQ:092040) Is Growing Earnings But Are They A Good Guide?
Dec 30Is Now The Time To Put Amicogen (KOSDAQ:092040) On Your Watchlist?
Dec 15Did You Miss Amicogen's (KOSDAQ:092040) 37% Share Price Gain?
Nov 30Financial Position Analysis
Short Term Liabilities: A092040's short term assets (₩156.1B) do not cover its short term liabilities (₩174.2B).
Long Term Liabilities: A092040's short term assets (₩156.1B) exceed its long term liabilities (₩73.2B).
Debt to Equity History and Analysis
Debt Level: A092040's net debt to equity ratio (50%) is considered high.
Reducing Debt: A092040's debt to equity ratio has increased from 21.8% to 67.6% over the past 5 years.
Debt Coverage: A092040's debt is not well covered by operating cash flow (5.8%).
Interest Coverage: A092040's interest payments on its debt are not well covered by EBIT (0.1x coverage).